Bringing natural products into the fold - exploring the therapeutic lead potential of secondary metabolites for the treatment of protein-misfolding-related neurodegenerative diseases.
about
Illicium sesquiterpenes: divergent synthetic strategy and neurotrophic activity studiesInteraction of Aβ(25-35) fibrillation products with mitochondria: Effect of small-molecule natural products.trans-(-)-ε-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington Disease.Natural biomolecules and protein aggregation: emerging strategies against amyloidogenesisSynthesis of the tetracyclic core of Illicium sesquiterpenes using an organocatalyzed asymmetric Robinson annulation.Neurotrophic natural products: chemistry and biology.Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis.Neuroprotective effect of aqueous extract of Selaginella delicatula as evidenced by abrogation of rotenone-induced motor deficits, oxidative dysfunctions, and neurotoxicity in mice.Gallotannins and Tannic Acid: First Chemical Syntheses and In Vitro Inhibitory Activity on Alzheimer's Amyloid β-Peptide Aggregation.Mechanisms and Effects Posed by Neurotoxic Products of Cyanobacteria/Microbial Eukaryotes/Dinoflagellates in Algae Blooms: a Review.Synthesis and Neurotrophic Activity Studies of Illicium Sesquiterpene Natural Product Analogues.Dihydroartemisinin treatment of multiple myeloma cells causes activation of c-Jun leading to cell apoptosis.Bioactive compounds from endemic plants of Southwest Portugal: inhibition of acetylcholinesterase and radical scavenging activities.
P2860
Q34335118-8915B2EC-F2B9-4171-AFB3-F923D86FC13AQ35314500-0A45EB42-5EC6-4375-A26D-E5C4CA133D05Q36098005-CC6614E9-2019-4EFA-A3EF-0525A40B14B6Q36538570-1BFDAD1D-B8AF-4EBF-80C8-062C25B03853Q36982425-29B724B9-343A-44A1-8223-E4385F57B7D3Q37623342-1A7A02EB-9AC6-45CB-B36B-D9156250F9A0Q38022265-45775D48-F28C-4EAA-BDCC-0A5B3928809AQ44593403-621BF028-B032-4EE7-9799-C9B247D2137BQ46797580-C840850D-D36B-4DE6-AF4B-A80573899BE6Q47760384-F3921E95-9E69-4932-BAEA-D776643AD6B7Q48373394-5081DB53-4E6F-4B5E-80EF-B6F99034C41CQ50053462-D46523CF-BDCC-4A43-9DF0-5214BF3D0E0CQ52802923-AE8E57B8-AE58-40F8-9CBA-8331524F9459
P2860
Bringing natural products into the fold - exploring the therapeutic lead potential of secondary metabolites for the treatment of protein-misfolding-related neurodegenerative diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bringing natural products into ...... ed neurodegenerative diseases.
@en
Bringing natural products into ...... ed neurodegenerative diseases.
@nl
type
label
Bringing natural products into ...... ed neurodegenerative diseases.
@en
Bringing natural products into ...... ed neurodegenerative diseases.
@nl
prefLabel
Bringing natural products into ...... ed neurodegenerative diseases.
@en
Bringing natural products into ...... ed neurodegenerative diseases.
@nl
P2860
P356
P1476
Bringing natural products into ...... ed neurodegenerative diseases.
@en
P2093
P Matthew Joyner
Robert H Cichewicz
P2860
P356
10.1039/C0NP00017E
P577
2010-10-07T00:00:00Z